United-Guardian reports Q2 EPS 21c vs. 10c last year

Reports Q2 revenue $3.39M vs. $2.65M last year. CEO Donna Vigilante stated, “We are pleased to announce that sales increased for both Q2 and the first six months of 2024 compared with the same periods in 2023. Cosmetic ingredient sales increased by 84% in the second quarter and 115% for the first six months of 2024. This increase was primarily attributable to purchases from our largest cosmetic distributor. Sales of medical lubricants increased as well for both the second quarter and first six months of 2024 by 15% and 9% respectively. Pharmaceutical product sales increased in the second quarter by 3% but decreased 13% for the first six months of 2024. The decrease for the six-month period was attributable to a shutdown we experienced with our contract manufacturer for Renacidin late last year. Renacidin production resumed in late March, and sales are in the process of recovering.”